[家用粉尘虫过敏的诊断中的陷]
P Huber1, S Becker2, M Gröger3
1Klinik und Poliklinik für Hals-Nasen-Ohrenheilkunde, Klinikum der Ludwig-Maximilians-Universität München, Marchioninistr. 15, 81377, München, Deutschland.
HNO
|February 15, 2024
概括
为有效的过敏原免疫疗法 (AIT) 诊断家用灰尘 (HDM) 过敏是具有挑战性的. 高质量蛋白敏感性的临床相关性需要进一步评估IgE水平和特定组件测试.
科学领域:
- 过敏原免疫疗法免疫疗法
- 免疫学 免疫学 免疫学
- 呼吸系统药物 呼吸系统药物
背景情况:
- 室内灰尘 (HDM) 是一个主要的室内过敏原,引起过敏性鼻炎和喘.
- 过敏原免疫疗法 (AIT) 是对HDM过敏的唯一因果治疗方法.
- 对临床相关的HDM敏感性的准确诊断对于启动AIT至关重要.
研究的目的:
- 评估诊断挑战,以确定HDM敏感化的临床相关性.
- 评估IgE标位和分子敏感性概况在预测过敏方面的有用性.
- 确定对AIT启动进行过敏原诱导测试的必要性.
主要方法:
- 审查现有的关于HDM敏感化和过敏诊断的文献.
- 对HDM提取物和特定成分的IgE抗体水平的分析 (Derp 1, Derp 2, Derp 23).
- 评估患者病史和临床相关性评估.
主要成果:
- IgE标位和敏感度与过敏风险相关,但没有明确的值.
- 在巴伐利亚南部,der p 23敏感性患病率很低,不足以区分所有HDM过敏.
- 仅仅患者病史不足以评估HDM敏感化的临床相关性.
结论:
- 确定HDM敏感化的临床相关性仍然是一个诊断挑战.
- 目前的血清学标记不足以确定过敏诊断.
- 在启动HDM AIT之前,仍然需要对过敏原引起测试.
相关概念视频
Allergic Reactions
27.4K
Overview
27.4K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma: Pathogenesis and Management
398
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
398
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
297
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
297


